drugset / Trial / NCT07257120
KarXT Concentrations in the Breast Milk and Plasma of Lactating Females
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to characterize the PK of xanomeline and trospium in breast milk and plasma in healthy lactating female participants, following multiple oral administration of KarXT in healthy lactating participants.
Timeline
- Start
- 2026-01-09
- Primary completion
- 2026-06-08
- Completion
- 2026-06-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Xanomeline/trospium chloride | Unknown | — | Oral |
Indications
No indication recorded.